Short Term Follow-up of Patent Implanted With the B-BOP Lock Plate
- Conditions
- Vicious Callus on M1Hallux ValgusHallux Varus
- Registration Number
- NCT01284998
- Lead Sponsor
- Integra LifeSciences Services
- Brief Summary
In case of deformities of the forefoot (Hallux-valgus, Hallux-varus), the basal osteotomy may be more indicated than the distal osteotomy as it allows to achieve a greater degree of correction.
However, weight bearing forces on the head of the first metatarsal acting at a distance from the osteotomy site subject the construct to an important dorsiflexion stress. Fixation strength being the important consideration led to design the B-BOP® Lock plate, specifically dedicated to basal osteotomy of the first metatarsal, with the following characteristics:
* plantar positioning to obtain the best stability and resistance while reducing the implant bulkiness;
* anatomical shape adapted to the plantar curve of the first metatarsal. Taking advantages of the most appropriated anatomical site to implant the B-BOP® Lock plate directly on tension, it offers an innovative and unique basal osteotomy fixation solution.
The B-BOP® Lock osteosynthesis plate benefits now of the Surfix locking screws technology.
The purpose of this study is to collect and publish data from several centers, several users.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 85
- Subject of either gender who needs a fixation of osteotomy of the basis of the first metatarsal for whose surgeon has recommended that a B-BOP® Lock plate from INTEGRA be implanted can be enrolled in this study.
- Age ≥ 18 years
- Have willingness to give his/her data transfer authorisation
- Contraindication of the implantation of the B-BOP Lock plate
- History of prior mental illness or patient demonstrates that their mental capacity may interfere with their ability to follow the study protocol
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of device related complications. 12 months Iprovement of American Orthopaedic Foot and Ankle Society Hallux Metatarsophalangeal-lnterphalangeal Scale (AOFAS HMIS) score 12 months
- Secondary Outcome Measures
Name Time Method X rays evaluation 3 and12 months Pain using a visual analog scale 3 and 12 months Function assessment 3 and 12 Months Clinical assessment 3 and 12 months
Trial Locations
- Locations (3)
Centre Hospitalier universitaire Notre Dame de secours
🇱🇧Byblos, Lebanon
Wrexham Maelor Hospital
🇬🇧Wrexham, United Kingdom
Clinique du Mont Louis
🇫🇷Paris, France